학술논문

Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma.
Document Type
Article
Source
Cancer Cell. Jun2022, Vol. 40 Issue 6, p587-589. 3p.
Subject
*MULTIPLE myeloma
*IMMUNE response
*COVID-19 vaccines
*VACCINATION
*MELPHALAN
*SARS-CoV-2 Omicron variant
Language
ISSN
1535-6108